Torrvis Pharmaceuticals Private Limited

This company deals with the production and distribution of various pharmaceutical and herbal products.

2020 | South West Delhi, Delhi (India) | Active
Last Updated:

Torrvis Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 3 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 2.10 Cr
  • Revenue Growth 66.60%
  • Profit Growth 12.21%
  • Ebitda 385.44%
  • Net Worth 55.57%
  • Total Assets 753.97%

About Torrvis Pharmaceuticals

Torrvis Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 December 2020 (Four years and three months 22 days old ). Its registered office is in South West Delhi, Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹2.10 Cr.

Sanjay Gupta and Meenakshi Gupta serve as directors at the Company.

Company Details

  • Location

    South West Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233DL2020PTC374452

  • Company No.

    374452

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    11 Dec 2020

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

Who are the key members and board of directors at Torrvis Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Sanjay Gupta Country flag representing In Director 11-Dec-2020Current
Meenakshi Gupta Country flag representing In Director 11-Dec-2020Current

Financial Performance of Torrvis Pharmaceuticals.

Torrvis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.6% increase. The company also saw a substantial improvement in profitability, with a 12.21% increase in profit. The company's net worth Soared by an impressive increase of 55.57%.

Torrvis Pharmaceuticals revenue growth over time
Torrvis Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
66.60%
Revenue from Operations
75.86%
Total Assets
753.97%
Profit or Loss
12.21%
Net Worth
55.57%
EBITDA
385.44%

What is the Ownership and Shareholding Structure of Torrvis Pharmaceuticals?

Unlock access to Torrvis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹21.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 2.10 Cr

Latest Charge Details

DateLenderAmountStatus
18 Sep 2023Hdfc Bank Limited₹2.10 CrOpen

How Many Employees Work at Torrvis Pharmaceuticals?

Torrvis Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Torrvis Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Torrvis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Torrvis Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Torrvis Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Torrvis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 21.00 M with Charge ID 100826078 was registered on 18 Sep 2023.

  • Balance Sheet

    Torrvis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

  • Director Appointment

    Sanjay Gupta was appointed as a Director was appointed as a Director on 11 Dec 2020 & has been associated with this company since 4 years 3 months .

  • Director Appointment

    Meenakshi Gupta was appointed as a Director was appointed as a Director on 11 Dec 2020 & has been associated with this company since 4 years 3 months .

  • Company Incorporation

    Torrvis Pharmaceuticals Private Limited was registered on 11 Dec 2020 with Roc Delhi & aged 4 years 3 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Torrvis Pharmaceuticals Private Limited?

    Torrvis Pharmaceuticals Private Limited was incorporated on 11 Dec 2020.

  • What is authorized share capital and paid-up capital of Torrvis Pharmaceuticals Private Limited?

    The authorized share capital of Torrvis Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Torrvis Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Torrvis Pharmaceuticals Private Limited.

    • Sanjay Gupta
    • Meenakshi Gupta

  • What is the registered address of Torrvis Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Torrvis Pharmaceuticals Private Limited is Flat No.302 Narmada Blk N-5 Sec-D Pkt-6 Vasant Kunj, India, Delhi, 110070.

  • What is the corporate identification number (CIN) and company number of Torrvis Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Torrvis Pharmaceuticals Private Limited is U24233DL2020PTC374452 and the company number is 374452 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Torrvis Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Torrvis Pharmaceuticals Private Limited has risen by 66.60%.

  • What change has been observed in the net worth of Torrvis Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Torrvis Pharmaceuticals Private Limited has experienced an upsurge of 55.57%.

  • What are the total open charges for Torrvis Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Torrvis Pharmaceuticals Private Limited amount to ₹ 2.10 Cr.

  • When was the last Balance Sheet of Torrvis Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Torrvis Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.